Catheter Precision Inc. Total Liabilities
Catheter Precision Inc. total liabilities. Based on the latest financial reports, Catheter Precision Inc. (VTAK) has total liabilities worth $9.21 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check VTAK cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Catheter Precision Inc. (2016–2025)
Total liabilities of Catheter Precision Inc. from 2016 to 2025. This chart illustrates how Catheter Precision Inc.'s total liabilities have evolved over time, based on quarterly financial data.
Catheter Precision Inc. Competitors by Total Liabilities
The table below lists competitors of Catheter Precision Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BioNexus Gene Lab Corp Common stock
NASDAQ:BGLC
|
USA | $804.97K |
|
Invion Ltd
AU:IVX
|
Australia | AU$1.24 Million |
|
Brown Advisory US Smaller Companies PLC
LSE:BASC
|
UK | GBX1.55 Million |
|
Majedie Investments
LSE:MAJE
|
UK | GBX813.00K |
|
Crown LNG Holdings Limited Warrants
NASDAQ:CGBSW
|
USA | $16.20 Million |
|
PREMIA FINANCE O.N.
F:81U
|
Germany | €1.78 Million |
|
Cosmo Metals Ltd
AU:CMO
|
Australia | AU$645.79K |
Liability Composition Analysis (2016–2025)
This chart breaks down Catheter Precision Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Catheter Precision Inc. balance sheet assets.
Liquidity & Leverage Metrics
Catheter Precision Inc. Total Liabilities Ratios Explained
Catheter Precision Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Catheter Precision Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Catheter Precision Inc. (2016–2025)
The table below shows the annual total liabilities of Catheter Precision Inc. from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $9.21 Million | -42.49% |
| 2024-12-31 | $16.01 Million | +67.80% |
| 2023-12-31 | $9.54 Million | +25.96% |
| 2022-12-31 | $7.58 Million | +2.78% |
| 2021-12-31 | $7.37 Million | -40.03% |
| 2020-12-31 | $12.29 Million | +12.44% |
| 2019-12-31 | $10.93 Million | +49.13% |
| 2018-12-31 | $7.33 Million | -61.18% |
| 2017-12-31 | $18.88 Million | +203.50% |
| 2016-12-31 | $6.22 Million | -- |
About Catheter Precision Inc.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally … Read more